Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Lifetime Data Anal. 2018 Dec 17;25(3):546–568. doi: 10.1007/s10985-018-09459-5

Fig. 2.

Fig. 2

The estimated AMD progression profiles separated by a top SNP rs2672599 (from ARMS2 gene region): (a) the eye-level K-M plot, with the total number of eyes and the percentage of progressed eyes in each genetic group given in parenthesis; (b) the (Clayton-WB) estimated joint progression-free probability contours (the baseline severity score and age are fixed at their mean values: 5.8 and 69.6, respectively); (c) the (Clayton-WB) estimated conditional progression-free probabilities of remaining years (since year 5) for one eye, given the other eye has been progressed by 5 year (the baseline severity score and age are also fixed at their mean values: 5.8 and 69.6, respectively).